XML 47 R34.htm IDEA: XBRL DOCUMENT v3.25.2
Revenues (Tables)
 6 Months Ended
Jun. 30, 2025
Revenue from Contract with Customer [Abstract]  
Schedule of Product Revenue The table below presents the Company’s gross and net product revenue ($ in thousands):
Three Months Ended June 30,Six Months Ended June 30,
2025202420252024
Product revenue - gross116,530 106,611 228,863 199,723 
Less: Rebates and sales returns(7,445)(6,505)(14,128)(12,468)
Product revenue - net109,085 100,106 214,735 187,255 
Schedule of Disaggregation of Net Revenue
The following table presents the Company’s net revenue by commercial program ($ in thousands):
Three Months Ended June 30,Six Months Ended June 30,
2025202420252024
ZEJULA41,042 44,999 90,571 90,500 
VYVGART / VYVGART Hytrulo26,497 23,190 44,602 36,352 
NUZYRA14,292 12,295 29,410 22,208 
OPTUNE12,355 12,584 23,718 25,064 
QINLOCK8,536 7,038 17,045 13,131 
XACDURO4,622 — 5,739 — 
AUGTYRO1,399 — 3,025 — 
Other (i)342 — 625 — 
Product revenue - net109,085 100,106 214,735 187,255 
(i)Other includes product candidates sold in patient programs prior to commercialization.